Page last updated: 2024-09-04

ym 09151-2 and cysteine

ym 09151-2 has been researched along with cysteine in 2 studies

Compound Research Comparison

Studies (ym 09151-2)	Trials (ym 09151-2)	Recent Studies (post-2010) (ym 09151-2)	Studies (cysteine)	Trials (cysteine)	Recent Studies (post-2010) (cysteine)
249	6	13	40,132	418	11,457

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Javitch, JA; Kaback, J; Karlin, A; Li, X	1
Chen, J; Fu, D; Javitch, JA	1

Other Studies

2 other study(ies) available for ym 09151-2 and cysteine

Article	Year
A cysteine residue in the third membrane-spanning segment of the human D2 dopamine receptor is exposed in the binding-site crevice. Proceedings of the National Academy of Sciences of the United States of America, 1994, Oct-25, Volume: 91, Issue:22 Topics: Amino Acid Sequence; Benzamides; Binding Sites; Cell Line; Cysteine; Dopamine Antagonists; Embryo, Mammalian; Humans; Kidney; Kinetics; Mutagenesis, Site-Directed; Protein Conformation; Receptors, Dopamine D2; Recombinant Proteins; Sequence Homology, Amino Acid; Structure-Activity Relationship; Sulfonic Acids; Transfection	1994
Differentiating dopamine D2 ligands by their sensitivities to modification of the cysteine exposed in the binding-site crevice. Molecular pharmacology, 1996, Volume: 49, Issue:4 Topics: Benzamides; Binding Sites; Cell Line; Cysteine; Humans; Mutagenesis, Site-Directed; Receptors, Dopamine D2; Spiperone; Structure-Activity Relationship	1996

Article

Year

A cysteine residue in the third membrane-spanning segment of the human D2 dopamine receptor is exposed in the binding-site crevice.

Proceedings of the National Academy of Sciences of the United States of America, 1994, Oct-25, Volume: 91, Issue:22

Topics: Amino Acid Sequence; Benzamides; Binding Sites; Cell Line; Cysteine; Dopamine Antagonists; Embryo, Mammalian; Humans; Kidney; Kinetics; Mutagenesis, Site-Directed; Protein Conformation; Receptors, Dopamine D2; Recombinant Proteins; Sequence Homology, Amino Acid; Structure-Activity Relationship; Sulfonic Acids; Transfection

1994

Differentiating dopamine D2 ligands by their sensitivities to modification of the cysteine exposed in the binding-site crevice.

Molecular pharmacology, 1996, Volume: 49, Issue:4

Topics: Benzamides; Binding Sites; Cell Line; Cysteine; Humans; Mutagenesis, Site-Directed; Receptors, Dopamine D2; Spiperone; Structure-Activity Relationship

1996